Xvivo Perfusion AB (publ)
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Xvivo Perfusion AB (publ) generated cash of $46,287,000, which is more than the previous year. Cash used in financing activities reached the amount of $418,547,000 last year. Net change in cash is therefore $299,543,000.
Cash Flow
| 2014 | -3.74M | -15.36M | 62.69M |
|---|---|---|---|
| 2015 | 8.57M | -14.29M | -1.46M |
| 2016 | 12.55M | -29.72M | 244K |
| 2017 | 22.19M | -35.52M | 184.79M |
| 2018 | 23.62M | -53.19M | 19.20M |
| 2019 | 29.50M | -83.84M | 25.55M |
| 2020 | -12.26M | -266.53M | 482.76M |
| 2021 | -12.05M | -187.70M | 234.61M |
| 2022 | 27.85M | -197.62M | -6.84M |
| 2023 | 46.28M | -161.61M | 418.54M |
0RKL.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 246.54M | 398.69M | 354.23M | 159.94M | 187.06M | 195.32M | 24.87M | 41.23M | 48.20M | 4.13M |
Operating activities | ||||||||||
Net income | 91.82M | 22.31M | 6.66M | -57.26M | 5.29M | 17.49M | 7.45M | 2.99M | 7.39M | 6.71M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 30.86M | 42.16M | 32.25M | 30.03M | 24.86M | 16.92M | 14.91M | 13.21M | 11.63M | 4.72M |
Stock-based compensation expense | 2.30M | 0 | 2.60M | 18.26M | 7.04M | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 2.30M | 0 | 2.60M | 18.26M | 7.04M | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -25.03M | -26.86M | -8.29M | 20.58M | -542K | 0 | -1.01M | 0 | -6.02M | 0 |
Inventories | -33.48M | -6.32M | -13.80M | -14.15M | -8.47M | -2.97M | 822K | -2.37M | -1.13M | -5.48M |
Accounts payable | 19.29M | 11.01M | -1.12M | -10.92M | 7.31M | 0 | 4.40M | 0 | 0 | 0 |
Cash generated by operating activities | 46.28M | 27.85M | -12.05M | -12.26M | 29.50M | 23.62M | 22.19M | 12.55M | 8.57M | -3.74M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 179.43M | -401K | -536K | -151K | 0 | -71K | 0 | -1.08M | -393K |
Investments In Property Plant And Equipment | -43.01M | -130.94M | -94.07M | -64.67M | -83.69M | -54.70M | -34.93M | -20.51M | -13.20M | -14.96M |
Acquisitions Net | -17.68M | -67.44M | -93.22M | -201.31M | 0 | 0 | -518K | -9.54M | 0 | 0 |
Cash generated by investing activities | -161.61M | -197.62M | -187.70M | -266.53M | -83.84M | -53.19M | -35.52M | -29.72M | -14.29M | -15.36M |
Financing activities | ||||||||||
Common Stock Issued | 429.25M | 815K | 245.35M | 488.43M | 28.9M | 19.20M | 184.79M | 244K | -1.46M | 69.35M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -368K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -5.94M | -5.66M | -3.34M | 0 | 0 | 0 | 0 | -6.65M |
Cash used in financing activities | 418.54M | -6.84M | 234.61M | 482.76M | 25.55M | 19.20M | 184.79M | 244K | -1.46M | 62.69M |
Net Change In Cash | 299.54M | -152.15M | 44.46M | 194.29M | -27.11M | -8.25M | 170.45M | -16.36M | -6.96M | 44.07M |
Cash at end of period | 546.08M | 246.54M | 398.69M | 354.23M | 159.94M | 187.06M | 195.32M | 24.87M | 41.23M | 48.20M |